The regulatory agency clarifies that this is not an intervention, as it will not have management powers over the health plan operator
A National Agency for Supplementary Health (ANS), which regulates the sector of health insurance in Brazil, announced in an official note that it will establish a technical direction in the Prevent Senior, a company that has been suffering several accusations related to misconduct in the pandemic, such as having carried out an unauthorized scientific study, having used patients as guinea pigs without fully informing them or their family members, interrupting treatment in patients who could still survive, forcing doctors to prescribe the drugs in the ‘covid kit’ and falsifying certificates of death. Prevent Senior has been investigated by CPI from Pandemic, by Anvisa and by bodies such as the Public Ministry and the Civil Police of São Paulo, in addition to the ANS itself. The agency clarified that this is not an intervention in the company, but a closer monitoring.
The director of ANS, Paulo Rebello, had already announced that the technical direction at Prevent Senior would be established during testimony at the CPI of the Pandemic last week. In the note, the regulatory agency informs that it will not interfere in the operator’s management, but will follow up closely, with an employee working ‘in loco’ who will make requests and ongoing analysis of information and set goals to be met. According to ANS, so far two notices of infraction have been drawn up for Prevent Senior (lack of communication to beneficiaries about the “Covid kit” and restriction of the service provider’s activity).